Characterizing viral clearance kinetics in acute influenza
Philosophical Transactions B · 30.04.2026 · 381 (1949)
DOI: 10.1098/rstb.2024.0351 ↗Kurz gefasst
Fachartikel in der Zeitschrift Philosophical Transactions B, online erschienen am 30.04.2026. Verfasst von Phrutsamon Wongnak und 6 weiteren Autor:innen. Beteiligte Einrichtung: Mahidol-Oxford Tropical Medicine Research Unit (MORU), Faculty of Tropical Medicine, Mahidol University, Bangkok10400, Thailand. Hauptthemen laut MEDLINE: Influenza, Human, Influenza A virus, Influenza B virus, Antiviral Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wellcome Trust, NIHR National Institutes of Health Research.
Abstract (Originalsprache)
Pharmacometric assessment of antiviral efficacy in acute influenza informs treatment decisions and pandemic preparedness. We characterized natural viral clearance in acute influenza to guide phase II trial design using simulations based upon observed data. Standardized duplicate oropharyngeal swabs were collected daily over 14 days from 80 untreated low-risk Thai adults, with viral densities measured using quantitative polymerase chain reaction. We evaluated three models to describe viral clearance: exponential, bi-exponential and growth-and-decay. The growth-and-decay model provided the best fit, but the exponential decay model was the most parsimonious. The median viral clearance half-life was 10.3 h (interquartile range (IQR): 6.8–15.4h), varying by influenza type: 9.6 h (IQR: 6.2–13.0 h) for influenza A and 14.0 h (IQR: 10.3–19.3 h) for influenza B. Simulated trials using parameters from the exponential decay model showed that 148 patients per arm provide over 90% power to detect treatments accelerating viral clearance by 40%. Variation in clearance rates strongly impacted the power; doubling this variation would require 232 patients per arm for an antiviral with a 60% effect size. A sampling strategy with four swabs per day reduces the required sample size to 81 per arm while maintaining over 80% power. We recommend this approach to assess and compare current anti-influenza drugs. This article is part of the Theo Murphy meeting issue ‘Evaluating anti-infective drugs’.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Mahidol-Oxford Tropical Medicine Research Unit (MORU), Faculty of Tropical Medicine, Mahidol University, Bangkok10400, Thailand.
- Department of Tropical Hygiene, Faculty of Tropical Medicine, Mahidol University, Bangkok10400, Thailand.
- Department of Molecular Tropical Medicine and Genetics, Faculty of Tropical Medicine, Mahidol University, Bangkok10400, Thailand.
- Infection Clinical Academic Group, St George's Hospital NHS Foundation Trust, LondonSW17 0QT, UK.
- Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, OxfordOX3 7LF, UK.
- Infectious Diseases Data Observatory , OxfordOX3 7LG, UK.
ORCID-Profile: Phrutsamon Wongnak, Nicholas J White
Förderung
- Wellcome Trust
- NIHR National Institutes of Health Research
Zitieren
APA
Wongnak, P., Seers, T., Jittamala, P., Imwong, M., Schilling, W., Watson, J., & White, N. J. (2026). Characterizing viral clearance kinetics in acute influenza. Philosophical Transactions B, 381(1949). https://doi.org/10.1098/rstb.2024.0351
Vancouver
Wongnak P, Seers T, Jittamala P, Imwong M, Schilling W, Watson J, et al. Characterizing viral clearance kinetics in acute influenza. Philosophical Transactions B. 2026;381(1949). doi:10.1098/rstb.2024.0351
BibTeX
@article{Wongnak2026,
author = {Wongnak, Phrutsamon and Seers, Tim and Jittamala, Podjanee and Imwong, Mallika and Schilling, William and Watson, James and White, Nicholas J},
title = {Characterizing viral clearance kinetics in acute influenza},
journal = {Philosophical Transactions B},
year = {2026},
volume = {381},
number = {1949},
doi = {10.1098/rstb.2024.0351}
}
EUVIMED